SOTERA HEALTH COMPANY Increase (Decrease) in Income Taxes Payable
SOTERA HEALTH COMPANY (SHC) reported Increase (Decrease) in Income Taxes Payable of $497.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-06
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was -$3.55M.
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $4.05M.
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was $4.08M, a 28.67% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$1.33M, a 222.31% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for fiscal 2025 was -$5.46M, a 471.50% decline from fiscal 2024.
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for fiscal 2024 was $1.47M, a 59.09% increase from fiscal 2023.
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for fiscal 2023 was $924.00K.
- SOTERA HEALTH COMPANY increase (decrease) in income taxes payable for fiscal 2022 was -$12.33M, a 222.06% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $497.00K 10-Q · filed 2026-08-06 | $4.58M derived: sum of 3 quarters · filed 2026-08-06 | $3.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $4.05M 10-Q · filed 2026-05-05 | $8.13M derived: sum of 2 quarters · filed 2026-05-05 | $6.80M derived: sum of 3 quarters · filed 2026-05-05 | -$856.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.75M derived: sum of 2 quarters · filed 2026-02-24 | -$4.91M derived: sum of 3 quarters · filed 2026-08-06 | -$5.46M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$8.99M derived: sum of 2 quarters · filed 2026-08-06 | -$9.54M 10-Q · filed 2025-11-04 | -$3.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$7.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.21M 10-Q · filed 2026-08-06 | -$2.49M derived: sum of 3 quarters · filed 2026-08-06 | -$1.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$556.00K 10-Q · filed 2026-05-05 | $5.17M derived: sum of 2 quarters · filed 2026-05-05 | $6.26M derived: sum of 3 quarters · filed 2026-05-05 | $2.72M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.81M derived: sum of 2 quarters · filed 2026-02-24 | $3.28M derived: sum of 3 quarters · filed 2026-02-24 | $1.47M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$2.45M derived: sum of 2 quarters · filed 2025-11-04 | -$4.25M 10-Q · filed 2025-11-04 | $15.04M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$5.34M 10-Q · filed 2025-08-08 | $13.95M derived: sum of 3 quarters · filed 2026-02-24 | $9.65M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$1.81M 10-Q · filed 2025-05-01 | $17.48M derived: sum of 2 quarters · filed 2026-02-24 | $13.18M derived: sum of 3 quarters · filed 2026-02-24 | $8.67M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $19.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $14.99M derived: sum of 2 quarters · filed 2026-02-24 | $10.47M derived: sum of 3 quarters · filed 2026-02-24 | $924.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | -$4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$8.81M derived: sum of 2 quarters · filed 2024-11-05 | -$18.37M 10-Q · filed 2024-11-05 | -$5.65M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$14.07M 10-Q · filed 2024-08-05 | -$1.35M derived: sum of 3 quarters · filed 2025-02-27 | -$10.43M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$9.55M 10-Q · filed 2024-05-02 | $3.17M derived: sum of 2 quarters · filed 2025-02-27 | -$5.92M derived: sum of 3 quarters · filed 2025-02-27 | -$16.66M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $12.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.64M derived: sum of 2 quarters · filed 2025-02-27 | -$7.11M derived: sum of 3 quarters · filed 2025-02-27 | -$12.33M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$9.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$19.83M derived: sum of 2 quarters · filed 2023-11-01 | -$25.05M 10-Q · filed 2023-11-01 | -$11.33M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$10.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$15.97M 10-Q · filed 2023-08-03 | -$2.25M derived: sum of 3 quarters · filed 2024-02-27 | -$1.87M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$5.22M 10-Q · filed 2023-05-03 | $8.50M derived: sum of 2 quarters · filed 2024-02-27 | $8.88M derived: sum of 3 quarters · filed 2024-02-27 | $9.40M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $13.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $14.10M derived: sum of 2 quarters · filed 2024-02-27 | $14.62M derived: sum of 3 quarters · filed 2024-02-27 | $10.10M 10-K · filed 2024-02-27 |
| 2021-09-30 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $898.00K derived: sum of 2 quarters · filed 2022-11-02 | -$3.62M 10-Q · filed 2022-11-02 | $8.30M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $520.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$4.00M 10-Q · filed 2022-08-04 | $7.92M derived: sum of 3 quarters · filed 2023-02-28 | -$8.20M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$4.52M 10-Q · filed 2022-05-05 | $7.40M derived: sum of 2 quarters · filed 2023-02-28 | -$8.71M derived: sum of 3 quarters · filed 2023-02-28 | -$4.53M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $11.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$4.20M derived: sum of 2 quarters · filed 2023-02-28 | -$8.00K derived: sum of 3 quarters · filed 2023-02-28 | -$8.14M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$16.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$11.93M derived: sum of 2 quarters · filed 2021-11-10 | -$20.06M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$3.94M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$8.13M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$7.77M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |